NIH's Interagency Pain Research Coordinating Committee will file a formal objection to proposed opioid prescribing guidelines being drafted by CDC. Those guidelines would discourage primary care physicians from prescribing opioid pain medications. The committed reportedly believes there is little or no evidence to support many of the prescribing guidelines. The pain research committee includes representatives from FDA, Agency for Healthcare Research and Quality, Department of Veterans Affairs, Department of Defense, and the CDC itself. Sharon Hertz, FDA's director of the Division of Anesthesia, Analgesia and Addiction Products, says evidence cited to support the guidelines "is low to very low and that's a problem." CDC has admitted it rushed through the process, apparently to meet a January deadline.